New Paper Alert: Avutometinib and Defactinib Combination for Recurrent LGSOC – Phase II Trial Results
oncodaily.com/oncolibrary/...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #LGSOC #Avutometinib #Defactinib #OvarianCancer
5
0
0
0